IL21 and melanoma: For example, a novel vaccine targeting CD133(+) CD44(+) MSCs in melanoma, expressing a 6kDa early secretory antigenic target (ESAT-6) and secreting interleukin (IL)-21, significantly suppressed melanoma growth and metastasis in mice, extending survival (179).